Pfizer to ask FDA for emergency use of its COVID-19 vaccine in U.S.

Pharmaceutical company Pfizer said Friday it is asking federal regulators to allow emergency use of its COVID-19 vaccine.

Pfizer will make the request days after saying the company and German partner BioNTech's vaccine appeared to be 95% effective at the virus in late-stage clinical trials, according to the Associated Press.

The Food and Drug Administration can sometimes grant emergency-use authorization, before the final testing is fully complete.